TeselaGen Biotechnology

Dow AgroSciences, TeselaGen expanding advanced biodesign platform for Ag

Monday, August 28, 2017

Innovative use of molecular design technology is essential for discovering and developing new agricultural products at a faster pace. TeselaGen Biotechnology, and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical, announced they have entered a new phase in their collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work. The companies began collaborating in 2016.

[Read More]